Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [HEALTH]
2 clusters · 6 sources · 8 days · First seen · Last updated
Kenya medical manufacturing and health system development
Overview
Kenya is advancing its domestic medical manufacturing and healthcare infrastructure through private sector developments and international partnerships.
Initial progress includes the inauguration of a new syringe manufacturing plant by Crown Healthcare to strengthen local supply chains. Additionally, Universal Corporation Limited (UCL) has been selected by Merck to manufacture alimatravir, an investigational oral HIV pre-exposure prophylaxis (PrEP) pill, as part of a licensing arrangement involving three African nations.
Building on these developments, Kenya and Japan have expanded their health sector cooperation. This partnership focuses on reducing reliance on imported medical products by linking scientific research to the production of medicines, diagnostics, and medical technologies. The collaboration supports Kenya’s objective to manufacture its first locally produced vaccine by 2027 and aims to establish the country as a regional hub for health innovation through improved health financing, workforce development, and infrastructure.
Entities
Kenya · Merck · Universal Corporation Limited · Aden Duale · Japan
Timeline
-
[HEALTH] 3 sourcesKenya and Japan expand cooperation to strengthen health systems
Kenya and Japan are deepening health cooperation to boost local manufacturing of vaccines and medical technologies, aiming to reduce import reliance and support Kenya’s 2027 vaccine production goal.
-
[HEALTH] 3 sourcesKenya expands medical manufacturing with syringe plant and HIV pill deal
Kenya is boosting its medical manufacturing sector with a new syringe plant from Crown Healthcare and a deal for Universal Corporation Limited to produce a new monthly HIV prevention pill.
Sources
biznakenya.com · health.go.ke · healthcaremea.com · kenyans.co.ke · nairobibusinessmonthly.com · somalilandmohd.com